Flow cytometric detection of spontaneous apoptosis in human breast cancer using the TUNEL-technique

被引:45
作者
Ehemann, V [1 ]
Sykora, J [1 ]
Vera-Delgado, J [1 ]
Lange, A [1 ]
Otto, HF [1 ]
机构
[1] Univ Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany
关键词
flow cytometry; DNA fragmentation; cell cycle; spontaneous apoptosis; breast cancer;
D O I
10.1016/S0304-3835(03)00054-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microscopic detection of structural alterations is the most reliable method to identify apoptotic cells, which however, does not allow any correlation with cell cycle phases. Discrimination of individual cells within solid human tumors undergoing apoptotic death is possible by flow cytometry where apoptotic cells appear in a hypodiploid sub G0/1-peak as a consequence of partial DNA loss. To refer induction of apoptosis to cell cycle phases we adopted the terminal deoxynucleotidyl transferase nick-end-labelling (TUNEL) technique to flow cytometry which enables the detection of cellular DNA content and DNA fragmentation by multiparametric analysis. One thousand seven hundred human breast carcinomas were screened. In 40 cases (2.3%) of 1700 carcinomas we detected a hypodiploid sub -G0/1 apoptotic peak. The spontaneous apoptotic fractions within individual tumors ranged between 1.5 and 25%. A correlation (r(2) = 0.78) was found between apoptotic cells in sub-G0/1-peak measured by DNA-cytometry and TUNEL positive cells measured by multiparametric cytometry, because TUNEL reaction signed also cells with strand breaks. High proliferation indices correspond well (r(2) = 0.807) with the increased amount of TUNEL positive cells. Multiparametric flow cytometry for the combined determination of DNA-content and DNA-fragmentation by TUNEL offers not only the advantage of a higher apoptosis sensitivity but also enables the quantification of DNA fragmentation related to any cell cycle phase. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 31 条
  • [1] INSITU END-LABELING DETECTS DNA STRAND BREAKS IN APOPTOSIS AND OTHER PHYSIOLOGICAL AND PATHOLOGICAL STATES
    ANSARI, B
    COATES, PJ
    GREENSTEIN, BD
    HALL, PA
    [J]. JOURNAL OF PATHOLOGY, 1993, 170 (01) : 1 - 8
  • [2] EXPRESSION OF THE BCL-2 GENE FAMILY IN NORMAL AND MALIGNANT BREAST-TISSUE - LOW BAX-ALPHA EXPRESSION IN TUMOR-CELLS CORRELATES WITH RESISTANCE TOWARDS APOPTOSIS
    BARGOU, RC
    DANIEL, PT
    MAPARA, MY
    BOMMERT, K
    WAGENER, C
    KALLINICH, B
    ROYER, HD
    DORKEN, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (06) : 854 - 859
  • [3] Bedner E, 1999, CYTOMETRY, V35, P181, DOI 10.1002/(SICI)1097-0320(19990301)35:3<181::AID-CYTO1>3.0.CO
  • [4] 2-5
  • [5] Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1
  • [6] Dolnikov A, 1996, CANCER GENE THER, V3, P289
  • [7] Dong CM, 1997, AM J PATHOL, V151, P121
  • [8] DETECTION OF APOPTOSIS-ASSOCIATED DNA STRAND BREAKS IN FINE-NEEDLE ASPIRATION BIOPSIES BY IN-SITU END LABELING OF FRAGMENTED DNA
    GORCZYCA, W
    TUZIAK, T
    KRAM, A
    MELAMED, MR
    DARZYNKIEWICZ, Z
    [J]. CYTOMETRY, 1994, 15 (02): : 169 - 175
  • [9] Cell cycle specificity of apoptosis during treatment of leukaemias
    Halicka, HD
    Seiter, K
    Feldman, EJ
    Traganos, F
    Mittelman, A
    Ahmed, T
    Darzynkiewicz, Z
    [J]. APOPTOSIS, 1997, 2 (01) : 25 - 39
  • [10] BCL-2, A NOVEL REGULATOR OF CELL-DEATH
    HOCKENBERY, DM
    [J]. BIOESSAYS, 1995, 17 (07) : 631 - 638